EN
TR
Establishment of Acquired Sorafenib Resistance in Hepatocellular carcinoma cell line and Examination of EMT
Öz
Anahtar Kelimeler
Proje Numarası
THIZ-2023-1507
Kaynakça
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi:10.3322/caac.21492
- Colombo M, Maisonneuve P. Controlling liver cancer mortality on a global scale: Still a long way to go. J Hepatol. 2017;67:216–217. doi:10.1016/j.jhep.2017.05.004
- Kim DW, Talati C, Kim R. Hepatocellular carcinoma (HCC): Beyond sorafenib—Chemotherapy. J Gastrointest Oncol. 2017;8:256–265. doi:10.21037/jgo.2016.09.07
Ayrıntılar
Birincil Dil
İngilizce
Konular
Hücre Gelişimi, Proliferasyon ve Ölümü
Bölüm
Araştırma Makalesi
Yayımlanma Tarihi
21 Ekim 2023
Gönderilme Tarihi
19 Temmuz 2023
Kabul Tarihi
27 Eylül 2023
Yayımlandığı Sayı
Yıl 2023 Cilt: 6 Sayı: 3
APA
Aksoy, F., & Ak Aksoy, S. (2023). Establishment of Acquired Sorafenib Resistance in Hepatocellular carcinoma cell line and Examination of EMT. Acta Medica Nicomedia, 6(3), 348-351. https://izlik.org/JA26XD63LC
AMA
1.Aksoy F, Ak Aksoy S. Establishment of Acquired Sorafenib Resistance in Hepatocellular carcinoma cell line and Examination of EMT. Acta Med Nicomedia. 2023;6(3):348-351. https://izlik.org/JA26XD63LC
Chicago
Aksoy, Fuat, ve Seçil Ak Aksoy. 2023. “Establishment of Acquired Sorafenib Resistance in Hepatocellular carcinoma cell line and Examination of EMT”. Acta Medica Nicomedia 6 (3): 348-51. https://izlik.org/JA26XD63LC.
EndNote
Aksoy F, Ak Aksoy S (01 Ekim 2023) Establishment of Acquired Sorafenib Resistance in Hepatocellular carcinoma cell line and Examination of EMT. Acta Medica Nicomedia 6 3 348–351.
IEEE
[1]F. Aksoy ve S. Ak Aksoy, “Establishment of Acquired Sorafenib Resistance in Hepatocellular carcinoma cell line and Examination of EMT”, Acta Med Nicomedia, c. 6, sy 3, ss. 348–351, Eki. 2023, [çevrimiçi]. Erişim adresi: https://izlik.org/JA26XD63LC
ISNAD
Aksoy, Fuat - Ak Aksoy, Seçil. “Establishment of Acquired Sorafenib Resistance in Hepatocellular carcinoma cell line and Examination of EMT”. Acta Medica Nicomedia 6/3 (01 Ekim 2023): 348-351. https://izlik.org/JA26XD63LC.
JAMA
1.Aksoy F, Ak Aksoy S. Establishment of Acquired Sorafenib Resistance in Hepatocellular carcinoma cell line and Examination of EMT. Acta Med Nicomedia. 2023;6:348–351.
MLA
Aksoy, Fuat, ve Seçil Ak Aksoy. “Establishment of Acquired Sorafenib Resistance in Hepatocellular carcinoma cell line and Examination of EMT”. Acta Medica Nicomedia, c. 6, sy 3, Ekim 2023, ss. 348-51, https://izlik.org/JA26XD63LC.
Vancouver
1.Fuat Aksoy, Seçil Ak Aksoy. Establishment of Acquired Sorafenib Resistance in Hepatocellular carcinoma cell line and Examination of EMT. Acta Med Nicomedia [Internet]. 01 Ekim 2023;6(3):348-51. Erişim adresi: https://izlik.org/JA26XD63LC